Skip to content

The effect of aromatherapy with Orange Spring on nausea and vomiting

Investigating the Effect of Aromatherapy with Orange Spring on Chemotherapy Induced Nausea and Vomiting in Patients with Breast Cancer that Referred to Motahari Medica-Educational Center in Shiraz; A Randomized Control Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240305061177N1
Enrollment
100
Registered
2024-04-17
Start date
2024-06-14
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: In the intervention group, in addition to the standard drugs prescribed by the doctor, patients put two drops of orange spring essential oil of Tabib Daru Company,
Then they are asked to breath normally for 20 minutes and do this three times a day, morning (9:00), noon (15:00) and night (21:00) for 5 days and they fill out the questionnaire every day till 5 days

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Women aged 18- 80 years Women with a definite diagnosis of breast cancer in stage 2 and 3, without metastasis Treating with standard and identical AC-T chemotherapy protocol Women who were receiving chemotherapy and experienced nausea and/or vomiting of any severity Have at least two remaining chemotherapy courses using similar chemotherapeutic agents Not pregnant Being literate in reading and writing Having a healthy sense of smell and taste according to the patient's self-report Absence of known mental and Psychiatric diseases according to the patient's self-declaration No history of allergy to plants and Orang Spring according to the patient's self-report Not suffering from respiratory diseases such as asthma, allergic diseases and chronic obstructive pulmonary disease according to the patient's self-report. Using the same anti-nausea and vomiting regimen in all patients Non-use of other complementary medicine methods at the time of participating in the research Absence of epilepsy according to the patient's self-report

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in the study Failure to use the aroma according to the program provided to the patient Concurrent chemotherapy with radiotherapy Suffering any diseases or conditions that lead to nausea and vomiting, such as liver failure, kidney failure, digestive problems, acute stage of hepatitis B, obstruction of the digestive tract, and brain malignancies according to the patient's self-report. Anticipatory nausea and vomiting. It means nausea and vomiting that has a psychological aspect and usually occurs a few hours before chemotherapy, which is caused by talking or thinking about chemotherapy.

Design outcomes

Primary

MeasureTime frame
Nausea and Vomiting. Timepoint: Up to 5 days after the intervention. Method of measurement: Rhodes nausea and vomiting index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParsa Tabei

Shiraz University of Medical Sciences

parsatabei@sums.ac.ir+98 21 7789 2572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026